Anna Hansen is a cellular immunologist with over 10 years of biopharmaceutical experience in early and late-stage clinical development programs. Currently, they serve as the Director of Translational Medicine Strategy for IO Bispecifics in Oncology at AstraZeneca. Previously, Anna held positions at MedImmune as a Senior Scientist and Scientist II, and served as a Research Fellow at the National Institutes of Health. They completed a Doctor of Philosophy in Medicine at the University of Sydney, where they also engaged as an academic tutor. Anna's expertise spans therapeutic antibody development and immuno-oncology research.
Location
Gaithersburg, United States
This person is not in any teams
This person is not in any offices